Insider · CIK 0001229243
VANLENT ANNE
Reports to the SEC for 11 companies · NEW HAVEN, CT
Transactions
50
Companies
11
Filings
13
CIK
0001229243
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-06-03 | TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award | — |
| 2025-06-11 | TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award | — |
| 2024-06-13 | TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award | — |
| 2023-06-28 | TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award | — |
| 2022-11-30 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-11-30 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-11-30 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-11-30 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-11-30 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-11-30 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-11-30 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (Right to Buy)D Disposition to Issuer | — |
| 2022-06-23 | TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award | — |
| 2022-06-23 | TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award | — |
| 2021-11-30 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award | — |
| 2021-06-16 | TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award | — |
| 2020-12-16 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award | — |
| 2020-06-11 | TRVITrevi Therapeutics, Inc. · Nonstatutory Stock Option (right to buy)A Award | — |
| 2019-12-04 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award | — |
| 2019-06-12 | VXRTVaxart, Inc. · Stock Option (right to buy)A Award | — |
| 2019-06-12 | VXRTVaxart, Inc. · Stock Option (right to buy)A Award | — |
| 2019-05-09 | TRVITrevi Therapeutics, Inc. · Series A Preferred StockC Conversion | — |
| 2019-05-09 | TRVITrevi Therapeutics, Inc.P Purchase | +$50K |
| 2019-05-09 | TRVITrevi Therapeutics, Inc.C Conversion | — |
| 2019-05-09 | TRVITrevi Therapeutics, Inc. · Series C Preferred StockC Conversion | — |
| 2019-05-07 | TRVITrevi Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2018-11-15 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award | — |
| 2018-07-25 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award | — |
| 2018-07-25 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award | — |
| 2017-12-11 | Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2017-12-11 | Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2017-12-11 | Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2017-12-11 | Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2017-12-11 | Ocera Therapeutics, Inc.D Disposition to Issuer | −$19K |
| 2017-12-11 | Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2017-12-11 | Ocera Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2017-06-20 | Ocera Therapeutics, Inc.A Award | — |
| 2017-05-18 | VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award | +$9,800 |
| 2017-02-28 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award | — |
| 2016-12-22 | NOVELION THERAPEUTICS INC.Stock Option (Right to Buy)A Award | — |
| 2016-11-29 | Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2016-11-29 | Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2016-11-29 | NOVELION THERAPEUTICS INC.A Award | — |
| 2016-11-29 | Aegerion Pharmaceuticals, Inc.D Disposition to Issuer | — |
| 2016-11-29 | Aegerion Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer | — |
| 2016-08-17 | APPLIED GENETIC TECHNOLOGIES CORPStock Option (right to buy)A Award | — |
| 2016-06-14 | Ocera Therapeutics, Inc.Stock Option (Right to Buy)A Award | — |
| 2016-05-12 | VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award | +$30K |
| 2015-08-11 | VXRTVaxart, Inc. · Stock Option (Right to Buy)A Award | — |
| 2015-06-26 | Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2015-06-22 | VXRTVaxart, Inc.P Purchase | +$76.9K |
Recent filings
- 4VANLENT ANNE0001193125-26-257371SEC(opens sec.gov)
- 4VANLENT ANNE0000950170-25-086110SEC(opens sec.gov)
- 4VANLENT ANNE0000950170-24-073736SEC(opens sec.gov)
- 4VANLENT ANNE0001209191-23-040290SEC(opens sec.gov)
- 4VANLENT ANNE0001062993-22-023029SEC(opens sec.gov)
- 4/AVANLENT ANNE0001209191-22-040302SEC(opens sec.gov)
- 4VANLENT ANNE0001209191-22-038967SEC(opens sec.gov)
- 4VANLENT ANNE0001062993-21-012061SEC(opens sec.gov)
- 4VANLENT ANNE0001209191-21-041393SEC(opens sec.gov)
- 4VANLENT ANNE0001273636-20-000017SEC(opens sec.gov)
- 4VANLENT ANNE0000899243-20-016536SEC(opens sec.gov)
- 4VANLENT ANNE0001273636-19-000052SEC(opens sec.gov)
- 4VANLENT ANNE0001437749-19-012107SEC(opens sec.gov)
Companies
- Aegerion Pharmaceuticals, Inc.Director
- APPLIED GENETIC TECHNOLOGIES CORPDirector
- BARRIER THERAPEUTICS INCExec. V.P., CFO and Treasurer
- INTEGRA LIFESCIENCES HOLDINGS CORPDirectorIART
- NOVELION THERAPEUTICS INC.Director
- ObsEva SADirector
- Ocera Therapeutics, Inc.Director
- PENWEST PHARMACEUTICALS CODirector
- Traws Pharma, Inc.DirectorTRAW
- Trevi Therapeutics, Inc.DirectorTRVI
- Vaxart, Inc.DirectorVXRT
Address
C/O TREVI THERAPEUTICS, INC. 195 CHURCH STREET, 16TH FLOOR
NEW HAVEN, CT, 06510